Internal Strategy · May 15, 2026

Orivion Roadmap &
MVP to Public Beta.

A focused path from systematic-review screening to a paid public beta, built one phase at a time. Ship the differentiator, then expand.

Phase 1 · S6 collaboration in progress
10 total phases to full platform
16–20 weeks to public beta
Part 1 · MVP Scope

One full systematic review, end to end.

The MVP must let an early adopter complete a real review and cite Orivion in the methods section. Everything else is expansion.

Already Built
15
  • Dashboard & project wizard
  • Literature library
  • PubMed import
  • Study design + guideline engine
  • Statistical calculator
  • AI screening (manual mode)
  • Analysis, writing, tasks tabs
  • Pricing page & branding
  • Auth (magic link)
  • Supabase backend
  • Screening system S1–S5
In Progress
3
  • Blind mode integration
  • Conflict resolution system
  • Realtime collaboration polish
Must Add
8
  • Automated screening — the differentiator
  • PRISMA flow diagram generator
  • Reference deduplication
  • Bug pass + security audit
  • Stripe + feature gating
  • DOCX export
  • GDPR + legal pages
  • Onboarding flow polish
Not in MVP
7
  • Full-text screening
  • PDF upload & viewing
  • Data extraction
  • Risk of bias
  • R / statistics integration
  • Collaborative writing
  • Citation managers
Part 2 · Beta Launch Timeline

16–20 weeks. Two launches.

Honest math at 5–10 hrs/week. Closed beta first to learn, public beta when payments and the differentiating feature ship.

Aggressive Floor
Late Aug 2026
At 10 hrs/week consistently · no scope creep
Realistic Public Beta
Late Sep – Mid Oct 2026
16–20 weeks from today
Week 1 Week 20
S6
Automated Screening
PRISMA
Bug
Design
Sec
Stripe
Buffer
Finish S6
2 weeks
Automated screening
4–5 weeks
PRISMA + dedup + DOCX
2–3 weeks
Onboarding + bug pass
2 weeks
Frontend design pass
1–2 weeks
Security audit
1 week
Stripe + legal + Paddle
2–3 weeks
Buffer
2 weeks
Stage 1
Closed Beta
~10 weeks · Mid-July 2026
  • 30–50 invited researchers (friends + GCC PhD network)
  • S6 done, PRISMA flow, dedup, Stripe, legal pages
  • Free use — watch, fix, learn
  • Automated screening lands during this window
Stage 2
Public Beta
16–20 weeks · Sep–Oct 2026
  • Paddle / Polar approved · payments live
  • Automated screening shipped
  • Onboarding polished · campaign launches
  • Original "late May" target was unrealistic — revised
Part 3 · The Roadmap

10 phases. One path.

Sequenced for revenue first, then expansion. The MVP ends at Phase 5. Phases 6–10 are the year after.

1

Finish screening

In Progress MVP

Blind mode → Conflict resolution → Realtime polish. Don't skip ahead.

  • Blind mode
  • Conflict resolution
  • Realtime polish
2

Automated screening

Differentiator MVP

Complete the title/abstract story before touching anything else. Plan first (algorithmic + ML + AI hybrid), then build.

  • Algorithmic baseline
  • ML scoring
  • AI accelerated mode
  • Token cost calculator
3

PRISMA flow diagram generator

MVP

Small effort, huge value. Required for SR publication. Lets early users finish a real review and cite Orivion — even if full-text is done elsewhere temporarily.

  • Auto-generated counts
  • Downloadable SVG/PNG
  • Methods snippet
4

Quality + launch-readiness pass

MVP

The gate for Paddle / Polar approval. Do it once, properly.

  • Bug finding
  • Cochrane mapping
  • Security check
  • Frontend polish
  • User accounts
5

Monetization wiring

MVP

Stripe checkout + webhooks → subscription state + feature gating → submit Paddle / Polar. Can't validate willingness-to-pay without this.

  • Stripe checkout
  • Webhooks
  • Feature gating
  • Paddle / Polar submission
6

Full-text workflow

Post-Beta

PDF support (upload + view) → Full-text finder → Full-text screening UI. Annotation overlay is enough — PDF editing not worth it for v1.

7

Data extraction

Post-Beta

Structured extraction forms tied to study designs. Outcome variables, effect sizes, study characteristics.

8

Risk of bias

Post-Beta

Cochrane RoB 2, ROBINS-I, and other tools as structured assessments per included study.

9

Statistical analysis (R integration)

Post-Beta

Big architectural decision. Likely Supabase Edge Function or containerized R service. Evaluate WebR (R compiled to WASM) — runs client-side, no infra cost, no API tokens.

10

Collaborative writing + citation managers

Post-Beta

Biggest, riskiest build. Defer until paying users tell you they want this in-app rather than in Word / Google Docs.

Part 4 · The Gaps

What was missing from the list.

The original task list had features. These are the things that decide whether the launch actually works.

Pre-launch Essentials

Non-negotiable for beta

  • PRISMA flow diagram generator Added as Phase 3
  • Reference deduplication on import Foundational for screening — verify it exists
  • GDPR / DPA + cookie consent EU-hosted, medical data — mandatory
  • Project export / data portability Trust signal + GDPR requirement
  • Onboarding flow Critical for first-project conversion
  • Email flows beyond magic link Welcome, invitation, notification (Resend)
  • Performance testing Real SRs hit 50k records — test first

Differentiators

Worth considering

  • PROSPERO protocol registration Every serious SR registers there
  • Reporting templates beyond PRISMA PRISMA-S, PRISMA-ScR for scoping reviews
  • Help center / docs site SEO play + Paddle review signal

Operational

Don't fly blind

  • Analytics PostHog or Plausible — you're flying blind without it
  • Status page BetterStack can do this — trust signal for institutions
Part 5 · Bottom Line

Four principles to ship by.

i.

Lock the MVP list. Scope creep is the biggest risk — every "while I'm in there" addition costs a week.

ii.

Automated screening is non-negotiable. It is the differentiator that separates Orivion from a free Rayyan clone.

iii.

Closed beta first, public beta second. Use the gap to fix what real users break.

iv.

A delayed launch with the differentiator beats an on-time launch without it.